Sort
21,453 grants matching “tuberculosis”
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$2,101,022Khuanchai Supparatpinyo · Chiang Mai University · UM1 · FY2023 · AI
Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU)
$2,099,237Amita Gupta · Johns Hopkins University · UM1 · FY2023 · AI
Enhancing ATG-dependent Defense Against Pathogens w/Therapeutics Lead CP
$2,096,875Andrew J Phillips · Washington University · U19 · FY2015 · AI
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS
$2,094,303University Of North Carolina Chapel Hill · U01 · FY2002 · AI
ADULT AIDS CLINICAL TRIALS UNIT (AACTU)
$2,093,817University Of Rochester · U01 · FY2001 · AI
Chicago Clinical Trials Unit
$2,093,731Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2019 · AI
ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS (AVAR-T)
$2,091,723Warwick Britton · University Of Sydney · N01 · FY2024 · AI
Tuberculosis Research Unit
$2,090,900W. Henry Henry Boom · Case Western Reserve University · N01 · FY2008 · AI
NORTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$2,088,641Northwestern University · U01 · FY2000 · AI
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS
$2,086,388University Of North Carolina Chapel Hill · U01 · FY2003 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY PROGRAM FUNDING
$2,084,837Richard Stancil · Houston Department/Health/Human Srvs · U52 · FY2012 · PS
GHESKIO HIV Clinical Trial Unit
$2,084,335Jean William Pape · Gheskio Center · U01 · FY2010 · AI
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS
$2,083,770University Of North Carolina Chapel Hill · U01 · FY2004 · AI
Intracellular pathogens and innate immunity
$2,082,866Daniel A Portnoy · University Of California Berkeley · P01 · FY2020 · AI
Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU)
$2,082,659Amita Gupta · Johns Hopkins University · UM1 · FY2022 · AI
Intracellular pathogens and innate immunity
$2,079,300Daniel A Portnoy · University Of California Berkeley · P01 · FY2019 · AI
PROTEIN SECRETION AS A NOVEL DRUG TARGET FOR TUBERCULOSIS
$2,079,201Seattle Children'S Hospital · · FY2019 · Defense Health Agency
SAN DIEGO AIDS CLINICAL TRIAL UNIT
$2,078,195University Of California San Diego · U01 · FY2003 · AI
Development of an Optimized Adjuvanted TB Vaccine
$2,076,197Jay Evans · University Of Montana · N01 · FY2022 · AI
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$2,075,838Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,074,220Stephen A Spector · University Of California, San Diego · UM1 · FY2017 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,074,220Stephen A Spector · University Of California, San Diego · UM1 · FY2016 · AI
Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection
$2,073,222Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
New Animal Models for Tuberculosis
$2,069,412Michelle Linehan · Johns Hopkins University · N01 · FY2009 · AI
Autophagy-Inducting Peptides and Target Identification for Treatment of Viruses
$2,068,997Beth C Levine · Washington University · U19 · FY2018 · AI